These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2064307)

  • 1. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6.
    Gasperi-Campani A; Zoli W; Volpi A; Roncuzzi L; Amadori D
    Anticancer Res; 1991; 11(2):1007-11. PubMed ID: 2064307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro potentiation by lonidamine of the sc-RIP saporin 6 effect in a human metastatic breast cancer cell line.
    Roncuzzi L; Zoli W; Bajorko P; Gasperi-Campani A
    Anticancer Res; 1995; 15(3):773-6. PubMed ID: 7645957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity of saporin 6 on normal and leukemic hemopoietic cells.
    Gasperi-Campani A; Zauli G; Roncuzzi L; Valvassori L; Vitale L; Gaggioli L; Bagnara GP
    Exp Hematol; 1989 Aug; 17(7):755-9. PubMed ID: 2753083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.
    Delius M; Adams G
    Cancer Res; 1999 Oct; 59(20):5227-32. PubMed ID: 10537301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
    Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM
    Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
    Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M
    Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells.
    Piselli P; Vendetti S; Poccia F; Cicconi R; Mattei M; Bolognesi A; Stirpe F; Colizzi V
    J Biol Regul Homeost Agents; 1995; 9(2):55-62. PubMed ID: 9127634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience.
    Gobbi M; Barbieri L; Tazzari PL; Dinota A; Bontadini A; Rizzi S; Pession A; Stirpe F; Tura S
    J Exp Pathol; 1987; 3(4):359-62. PubMed ID: 3331647
    [No Abstract]   [Full Text] [Related]  

  • 11. Saporin 6 and lonidamine in primary cell cultures from human breast carcinomas: a synergistic effect.
    Gasperi-Campani A; Roncuzzi L; Zoli W; Amadori D
    Anticancer Drug Des; 1997 Mar; 12(2):91-8. PubMed ID: 9113064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
    Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
    Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
    Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse activity of sc-RIP saporin 6 on primary and metastatic melanoma cells in vitro.
    Gasperi-Campani A; Musa AR; Roncuzzi L
    Melanoma Res; 1993 Oct; 3(5):363-7. PubMed ID: 8292894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma.
    Glennie MJ; Brennand DM; Bryden F; McBride HM; Stirpe F; Worth AT; Stevenson GT
    J Immunol; 1988 Nov; 141(10):3662-70. PubMed ID: 3141503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia.
    Bolognesi A; Polito L; Farini V; Bortolotti M; Tazzari PL; Ratta M; Ravaioli A; Horenstein AL; Stirpe F; Battelli MG; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):145-52. PubMed ID: 16602630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
    Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.
    French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ
    Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins.
    Bolognesi A; Tazzari PL; Olivieri F; Polito L; Falini B; Stirpe F
    Int J Cancer; 1996 Nov; 68(3):349-55. PubMed ID: 8903477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
    Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
    Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.